A short journey through spirochetal infections;Les spirochètes dans tous leurs états

Revue Medicale Suisse

Volumn 6, Issue 243, 2010, Pages 721-726

  Giulieri, Stefano ^a   Tissot, Frédéric ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; DOXYCYCLINE; LIVER ENZYME;

ADULT; AGED; ARTICLE; BITE; BORRELIA INFECTION; CASE REPORT; ERYTHEMA CHRONICUM MIGRANS; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEPTOSPIROSIS; LYME DISEASE; LYMPHOCYTOPENIA; MALE; PERCEPTION DEAFNESS; SPIROCHETE INFECTION; SYPHILIS; THROMBOCYTOPENIA;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; BITES AND STINGS; ERYTHEMA; HUMANS; MALE; MIDDLE AGED; RATS; SPIROCHAETALES INFECTIONS;

EID: 77951289555     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Leptospirose - Erkrankungen in der Schweiz, Meldungen der Laboratorien und Ärzte 1988-1999. OFSP 1999.
2. Steffen I, Frei R, Widmer AF. Leptospirose: eine oft verpasste Diagnose? Epidemiologie und Diagnostik in der Schweiz. Praxis (Bern 1994);89:1257-1262
3. Bernasconi E, Gayer R, Busolini E, Mombelli G. Endemische und importierte schwere Leptospirose (Morbus Weil) in der Sudschweiz. Schweiz Med Wochenschr 2000;130:1487-1491
4. Bessire N. La leptospirose - une maladie professionnelle. Swiss medical forum 2004;513-514
5. Collecutt-Dietsche J, Rothen M, Klink M. Ikterus und ausgeprägte Myalgien bei einem jungen Mann. Swiss medical forum 2006:726-727
6. Jacques MC. Leptospirose ktéro-hémorragique. Rev Med Suisse romande 1984:104:841-845
7. Pantet O, Bonny O, Marchetti O, Prella M. Maladie de Weil: à propos d'un cas de leptospirose acquise en Suisse. Rev Med Suisse romande 2002;122:455-458
8. ** Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: A zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-771
9. Cerny A. Ettlin D, Betschen K. et al. Weil's disease after a rat bite. Eur J Med 1992;1:315-316
10. Gollop JH, Katz AR. Rudoy RC, Sasaki DM. Rat-bite leptospirosis. West J Med 1993;159:76-77
11. Adler H, Vonstein S, Deplazes P, Stieger C, Frei R. Prevalence of Leptospira spp. in various species of small mammals caught in an inner-city area in Switzerland. Epidemiol Infect 2002;128:107-109 (Pubitemid 34211211)
12. Suputtamongkol Y, Niwattayakul K, Suttinont C, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004;39:1417-1424
13. ** Boillat N, Frochaux V. Morsures d'animaux et risque infectieux. Rev Med Suisse 2008;4:2149-2155
14. * Glaser C, Lewis P, Wong S. Pet-, animal-, and vector-borne infections. Pediatr Rev 2000:21:219-232
15. Elliott SP. Rat bite fever and Streptobacillus moniliformis. Clin Microbiol Rev 2007;20:13-22.
16. Fontana-Binard L, Schultze D, Rojanavisut BS, et al. Premier cas de néphropathie épidemique endémique en Suisse. Rev Med Suisse 2008;4:1572-1575
17. Cumberland P, Everard CO, Levett PN. Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis. Am J Trop Med Hyg 1999;61:731-734
18. * Watt G. Padre LP, Tuazon ML, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433-435
19. Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg 1988;39:388-390
20. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th Edition. Oxford: Churchill Livingstone Elsevier. 2009.
21. * Panaphut T, Domrongkitchaipom S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 2003;36:1507-1513
22. McClain JB, Ballou WR, Harrison SM, Steinweg DL. Doxycycline therapy for leptospirosis. Ann Intern Med 1984:100:6964.
23. Watt G, Warrell DA. Leptospirosis and the JarischHerxheimer reaction. Clin Infect Dis 1995;20:1437-1438
24. re partie: épidemiologie et diagnostic. Rev Med Suisse 2006;2:919-924
25. e partie: clinique et traitement. Rev Med Suisse 2006:2:925-934
26. e partie: prévention, grossesse, états d'immunodéficience, syndrome post-borréliose de Lyme. Rev Med Suisse 2006;2:935-940
27. ** Steere AC. Lyme disease. N Engl J Med 2001;345:115-125
28. Stanek G, Strie F. Lyme disease: European perspective. Infect Dis Clin North Am 2008;22:327-39, vii.
29. Wormser GP, McKenna D, Carlin J, et al. Brief communication: Hematogenous dissemination in early Lyme disease. Ann Intern Med 2005;142:751-755 (Pubitemid 40593777)
30. Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for lyme disease. Clin Infect Dis 2008;47:188-195 (Pubitemid 351920619)
31. * Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:697-704.
32. Brouqui P, Bacellar F, Baranton G, et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 2004:10:1108-1132 (Pubitemid 40050854)
33. Weber R, Pusteria N, Loy M, et al. Serologische und klinische Daten weisen auf das endemische Vorkommen der humanen granulozytaren Ehrlichiose in der Nordostschweiz hin. Schweiz Med Wochenschr 2000:130:1462-1470
34. * Fenton KA, Breban R, Vardavas R, et al. Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis 2008;8:244-253
35. Office fédéral de la santé publique. Infections sexuellement transmissibles (IST) en Suisse de 2006 à 2008. 9 A.D. Nov 19.
36. Mishra S, Walmsley SL, Loutfy MR, et al. Otosyphilis in HIV-coinfected individuals: A case series from Toronto, Canada. AIDS Patient Care STDS 2008;22:213-219 (Pubitemid 351380154)
37. Abuzeid WM, Ruckenstein MJ. Spirochetes in otology: Are we testing for the right pathogens? Otolaryngol Head Neck Surg 2008;138:107-109
38. Yimtae K, Srirompotong S, Lertsukprasert K. Otosyphilis: A review of 85 cases. Otolaryngol Head Neck Surg 2007;136:67-71.
39. ** Marra CM. Update on neurosyphilis. Curr Infect Dis Rep 2009:11:127-134
40. * Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.
41. * Grivois JP, Caumes E. Neurosyphilis: quand fautil y penser? Rev Prat 2004;54:396-399
42. Zetola NM, Klausner JD. Syphilis and HIV infection: An update. Clin Infect Dis 2007;44:1222-1228
43. Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS. The Sanford guide to antimicrobial dierapy. 39th ed. Sperryville, USA: Antimicrobial Therapy, Inc., 2009.
44. Dowell ME, Ross PG, Musher DM, Cate TR, Baughn RE. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992;93:481-488
45. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000;30:540-544 (Pubitemid 30205302)
46. Smith NH, Musher DM, Huang DB. et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004:15:328-332
47. Marra CM, Maxwell CL, Smith SL, et al. Cerebro-spinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features. J Infect Dis 2004;189:369-376